International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 1 : 2419-2423
Research Article
Gastrointestinal Malignancies: A Case Series from District Hospital Kulgam, Jammu & Kashmir, North India
 ,
 ,
 ,
 ,
Received
Jan. 17, 2026
Accepted
Feb. 8, 2026
Published
Feb. 21, 2026
Abstract

Background: Gastrointestinal (GI) malignancies demonstrate marked geographic variation. The Kashmir Valley is recognized as a high-risk region for upper GI cancers, yet data from district-level hospitals remain scarce.

Objectives: To describe the demographic, endoscopic, anatomical, and histopathological profile of GI malignancies presenting to District Hospital Kulgam and to compare findings with published literature from Kashmir, India, and abroad.

Methods: A retrospective case series of biopsy-confirmed GI malignancies admitted from January 2023 to march 2024 was conducted. Demographic variables, lesion location, endoscopic/colonoscopy gross morphology, and histopathology were analyzed.

Results: A total of 23 patients were included. Mean age was 58.2 years, with a male predominance (M:F = 2.8:1). Upper GI malignancies accounted for 83% of cases, with gastric adenocarcinoma being the most common. Ulcero-proliferative lesions were the predominant endoscopic finding.

Conclusion: GI malignancies in Kulgam predominantly affect older males and are largely upper GI in origin, mirroring patterns reported from Kashmir and other Asian high-risk regions.

Keywords
INTRODUCTION

Gastrointestinal cancers remain a significant cause of cancer-related morbidity and mortality worldwide. Marked regional variation exists, with esophageal and gastric cancers disproportionately affecting populations in the “Asian esophageal cancer belt,” which includes the Kashmir Valley. Previous studies from tertiary care centers in Kashmir have documented a high burden of upper GI malignancies, particularly esophageal squamous cell carcinoma and gastric adenocarcinoma. However, published data from district hospitals are

limited.

This case series aims to characterize GI malignancies presenting to District Hospital Kulgam, providing insight into disease patterns at a secondary care level and comparing these findings with regional, national, and international literature.

 

MATERIALS AND METHODS

Study Design

Retrospective observational case series.

 

Study Setting

District Hospital Kulgam, Union Territory of Jammu & Kashmir, North India.                                                                                                                                                                            

Study Population

All patients with histopathologically confirmed gastrointestinal malignancy who underwent endoscopy or colonoscopy during the study period.

 

Data Collection

Data were extracted from hospital records and endoscopy registers, including:

  • Age and sex
  • Endoscopic/colonoscopy findings
  • Gross appearance of lesions
  • Anatomical location
  • Biopsy reports

 

Statistical Analysis

Descriptive statistics were used. Continuous variables are expressed as mean and range; categorical variables as frequencies and percentages.

 

RESULTS

  1. Demographic Profile
    • Total patients: 23
    • Males: 17 (73.9%)
    • Females: 6 (26.1%)
    • Male: Female ratio: 8:1
    • Mean age: 2 years
    • Age range: 15–75 years

 

Interpretation: A strong male predominance and presentation in the sixth decade align with regional GI cancer epidemiology.

 

2.   Types of Gastrointestinal Malignancies

Malignancy Type Number (n) Percentage (%)
Gastric adenocarcinoma 8 34.8
Esophageal adenocarcinoma 5 21.7
Esophageal squamous cell carcinoma 5 21.7
Colorectal carcinoma 4 17.4
Gastric MALT lymphoma 1 4.4

 

 

Upper GI malignancies (esophagus + stomach) constituted 82.6% of all cases.

 

3.     Anatomical Location of Lesions

Location N
Lesser curvature of stomach 5
Mid-esophagus 5
Gastroesophageal junction 4
Gastric antrum 3
Ascending colon 2
Sigmoid colon 1
Pylorus 1
Posterior gastric wall 1
Greater curvature 1

 

Key observation: Predominance of esophageal and gastric sites, especially lesser curvature and GE junction.

 

 

4.    Gross Endoscopic / Colonoscopic Appearance

Gross Appearance n %
Ulcero-proliferative 15 65.2
Ulcero-polypoidal 2 8.7
Ulcerative lesion 2 8.7
Polypoidal 2 8.7
Ulcero-infiltrative 1 4.3
Superficial raised lesion 1 4.3

 

Ulcero-proliferative growth was the dominant morphology, reflecting advanced presentation at diagnosis.

 

DISCUSSION

This case series from District Hospital Kulgam demonstrates several important epidemiological patterns:

 

Sex and Age Distribution

The strong male predominance (2.8:1) and mean age of ~58 years are comparable to reports from southern Kashmir, where male dominance and sixth-decade presentation are consistently observed.

 

Pattern of Malignancies

Upper GI cancers dominated this series, consistent with:

  • High esophageal cancer incidence in Kashmir (Romshoo et al.)
  • Gastric adenocarcinoma predominance reported in Srinagar-based studies

 

In contrast, Western populations report colorectal cancer as the leading GI malignancy, highlighting geographic variation.

 

Endoscopic Findings

The predominance of ulcero-proliferative and ulceroinfiltrative lesions parallels findings from other Indian and Asian studies, indicating delayed presentation and limited early screening.

 

Comparison with Other Studies

 

These similarities reinforce the classification of Kashmir as a high-risk upper GI cancer zone.

 

CONCLUSION

Gastrointestinal malignancies presenting to District Hospital Kulgam predominantly involve the upper GI tract, affect older males, and commonly present with advanced ulceroproliferative lesions. The findings closely mirror those from tertiary care centers in Kashmir, underscoring the need for early detection strategies, risk-factor modification, and improved endoscopic screening at the district level.

 

REFERENCES

  1. Romshoo GJ, et al. Cancer patterns in Kashmir Valley. Asian Pac J Cancer Prev. 2012;13:415–420.
  2. Jeelani U, et al. Epidemiologic and endoscopic profile of esophageal cancer in southern Kashmir. Mathews J Case Rep. 2024.
  3. Sharma MP, et al. Upper gastrointestinal cancers in India. Indian J Gastroenterol. 2011;30:63–70.
  4. Sung H, et al. Global cancer statistics 2020. CA Cancer J Clin. 2021;71:209–249.
  5. Bray F, et al. Global patterns of cancer incidence and mortality. Lancet. 2018;392:424–435.
  6. Mir SA, et al. Clinicopathological profile of carcinoma stomach in Kashmir. Int Surg J. 2019;6:1234–1239.
Recommended Articles
Research Article Open Access
Comparative Analgesic Efficacy of Intrathecal Fentanyl versus Intrathecal Midazolam as Adjuvants to Hyperbaric Bupivacaine for Elective Caesarean Section: A Randomized Double-Blinded Clinical Trial
2026, Volume-7, Issue 1 : 2477-2484
Research Article Open Access
Prevalence of Rifampicin resistance detected by TrueNat assay in suspected pulmonary cases in a teritiary care hospital, Kurnool
2026, Volume-7, Issue 1 : 2492-2496
Research Article Open Access
Study of prevalence of haemoglobin subtypes/variants in the ethnic population of Manipur
2026, Volume-7, Issue 1 : 2497-2500
Research Article Open Access
Cancer Pattern at a Tertiary Care hospital in Pir Panjal (Rajouri & Poonch) region of Jammu and Kashmir
2026, Volume-7, Issue 1 : 2485-2491
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 1
Citations
12 Views
7 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved